Diverse mechanisms of osteoblast spreading on hydroxyapatite and titanium

Biomaterials

Volumn 21, Issue 11, 2000, Pages 1121-1127

  Matsuura, T ^a   Hosokawa, R ^b   Okamoto, K ^b   Kimoto, T ^b   Akagawa, Y ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Fibronectin; Hydroxyapatite; Osteoblast; Spreading; Titanium; Vitronectin

Indexed keywords

ANTIBODIES; BIOCOMPATIBILITY; BONE; CELLS; PHOSPHATE MINERALS; PROTEINS; TITANIUM;

FIBRONECTIN; HYDROXYAPATITE; OSTEOBLASTS; OSTEOCONDUCTIVITY; VITRONECTIN;

IMPLANTS (SURGICAL);

ARGINYLGLYCYLASPARTIC ACID; FIBRONECTIN; HYDROXYAPATITE; INTEGRIN; INTEGRIN ANTIBODY; PROTEIN ANTIBODY; SIALIC ACID; SIALIDASE; TITANIUM; UNCLASSIFIED DRUG; VITRONECTIN;

ADSORPTION; ARTICLE; CELL SPREADING; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMPLANT; OSTEOBLAST; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; WESTERN BLOTTING;

BIOCOMPATIBLE MATERIALS; BLOOD PROTEINS; CELL LINE; CELL MOVEMENT; CHONDROITIN ABC LYASE; DURAPATITE; HUMANS; NEURAMINIDASE; OLIGOPEPTIDES; OSTEOBLASTS; TITANIUM;

EID: 0034102622     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(99)00264-1     Document Type: Article

References (37)

1. Block M.S., Kent J.N., Kay J.F. Evaluation of hydroxyapatite-coated titanium dental implants in dogs. J Oral Maxillofac Surg. 45:1987;601-607.
2. Block M.S., Finger I.M., Fontenot M.G., Kent J.N. Loaded hydroxyapatite-coated and grit-blasted titanium implants in dogs. Int J Oral Maxillofac implants. 4:1989;219-225.
3. Buser D., Schenk R.K., Steinemann S., Fiorellini J.P., Fox C.H., Stich H. Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J Biomed Mater Res. 25:1991;889-902.
4. Massas R., Pitaru S., Weinreb M.M. The effects of titanium and hydroxyapatite on osteoblastic expression and proliferation in rat parietal bone cultures. J Dent Res. 72:1993;1005-1008.
5. Ozawa S., Kasugai S. Evaluation of implant materials (hydroxyapatite, glass-ceramics, titanium) in rat bone marrow stromal cell culture. Biomaterials. 17:1996;23-29.
6. Okamoto K., Matsuura T., Hosokawa R., Akagawa Y. RGD peptides regulate the specific adhesion scheme of osteoblasts to hydroxyapatite but not to titanium. J Dent Res. 77:1998;481-487.
7. Schwartz M.A., Schaller M.D., Ginsberg M.H. Integrin. emerging paradigms of signal transduction Ann Rev Cell Dev Biol. 11:1995;549-599.
8. Danen E.H.J., Lafrenie R.M., Miyamoto S., Yamada K.M. Integrin signaling. cytoskeletal complexes, MAP kinase activation, and regulation of gene expression Cell Adhes Commun. 6:1998;217-224.
9. 3 increases bone alkaline phosphatase isoenzyme levels in human osteogenic sarcoma cells. J Biol Chem. 258:1983;6219-6225.
10. Komm B.S., Terpening C.M., Benz D.J., Graeme K.A., Gallegos A., Korc M., Greene G.L., O'Malley B.W., Haussler M.R. Estrogen binding, Receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science. 241:1988;81-84.
11. Clover J, Gowen M. Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? Bone 1994; 15:585-591.
12. Bowers K.T., Keller J.C., Randolph B.A., Wick D.G., Michaels C.M. Optimization of surface micromorphology for enhanced osteoblast responses in vitro. Int J Oral Maxillofac Implants. 7:1992;302-310.
13. Ruoslahti E. Stretching is good for a cell. Science. 276:1997;1345-1346.
14. Chen C.S., Mrksich M., Huang S., Whitesides G.M., Ingber D. Geometric control of cell life and death. Science. 276:1997;1425-1428.
15. Friedl P., Bröcker E.B., Zänker K.S. Integrins, cell matrix interactions and cell migration strategies. fundamental differences in leukocytes and tumor cells Cell Adhes Commun. 6:1998;225-236.
16. Zhu X., Assoian R.K. Integrin-dependent activation of MAP kinase. a link to shape-dependent cell proliferation Mol Biol Cell. 6:1995;273-282.
17. Bale D.M., Wohlfahrt L.A., Mosher D.F., Tomasini B., Sutton R.C. Identification of vitronectin as a major plasma protein adsorbed on polymer surfaces of different copolymer composition. Blood. 74:1989;2698-2706.
18. Preissner K.T. Structure and biological role of vitronectin. Ann Rev Cell Biol. 7:1991;275-310.
19. Leavesley D.I., Ferguson G.D., Wayner E.A., Cheresh D.A. Requirement of the integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol. 117:1992;1101-1107.
20. 5 integrins in avian neural crest cell adhesion and migration on vitronectin. Development. 120:1994;2687-2702.
21. Martinez-Morales J.R., Barbas J.A., Marti E., Bovolenta P., Edgar D., Rodriguez-Tebar A. Vitronectin is expressed in the vental region of the neural tube and promotes the differentiation of motor neurons. Development. 124:1997;5139-5147.
22. Ruoslahti E. Integrin signaling and matrix assembly. Tumor Biol. 17:1996;117-124.
23. Moursi A.M., Damsky C.H., Lull J., Zimmerman D., Doty S.B., Aota S., Globus R.K. Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci. 109:1996;1369-1380.
24. Moursi A.M., Globus R.K., Damsky C.H. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci. 110:1997;2187-2196.
25. Globus R.K., Doty S.B., Lull J.C., Holmuhamedov E., Humphries M.J., Damsky C.H. Fibronectin is a survival factor for differentiated osteoblasts. J Cell Sci. 111:1998;1385-1393.
26. Ruoslahti E. Proteoglycans in cell regulation. J Biol Chem. 264:1989;13369-13372.
27. Incardona F., Lawler J., Cataldo D., Panet A., Legrand Y., Foidart J.M., Legrand C. Heparin-binding domain, type 1 and type 2 repeats of thrombospondin mediate its interaction with human breast cancer cells. J Cell Biochem. 62:1996;431-442.
28. Kudo M., Kitajima K., Inoue S., Shiokawa K., Morris H.R., Dell A., Inoue Y. Characterization of the major core structures of the α-2-8-linked polysialic acid-containing glycan chains present in neural cell adhesion molecule in embryonic chick brains. J Biol Chem. 271:1996;32667-32677.
29. Collins B.E., Kiso M., Hasegawa A., Tropak M.B., Roder J.C., Crocker P.R., Schnaar R.L. Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J Biol Chem. 272:1997;16889-16895.
30. Kelm S., Schauer R. Sialic acids in molecular and cellular interactions. Int Rev Cytol. 175:1997;137-240.
31. Shanmugam V., Chackalaparampil I., Kundu G.C., Mukherjee A.B., Mukherjee B.B. Altered sialylation of osteopontin prevents its receptor-mediated binding on the surface of oncogenically transformed tsB77 cells. Biochemistry. 36:1997;5729-5738.
32. Bagambisa F.B., Joos U., Schilli W. Interaction of osteogenic cells with hydroxylapatite implant materials in vitro and in vivo. Int J Oral Maxillofac Implants. 5:1990;217-226.
33. Hjørting-Hansen E., Worsaae N., Lemons J.E. Histologic response after implantation of porous hydroxylapatite ceramic in humans. Int J Oral Maxillofac Implants. 5:1990;255-263.
34. Luyten F.P., Cunningham N.S., Vukicevic S., Paralkar V., Ripamonti U., Reddi A.H. Advances in osteogenin and related bone morphogenetic proteins in bone induction and repair. Acta Orthop Belg. 58:1992;263-267.
35. Takeshita F., Kuroki H., Yamasaki A., Suetsugu T. Histopathologic observation of seven removed endosseous dental implants. Int J Oral Maxillofac Implants. 10:1995;367-372.
36. Taylor J.C., Driscoll C.F., Cunningham M.D. Failure of a hydroxyapatite-coated endosteal dental implant. a clinical report J Prosthet Dent. 75:1996;353-355.
37. Cooper L.F. Biologic determinants of bone formation for osseointegration. clues for future clinical improvements J Prosthet Dent. 80:1998;439-449.